Wasatch Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38M | Buy |
|
|||||
|
2025
Q1 | $4.5M | Sell |
|
|||||
|
2024
Q4 | $9.42M | Sell |
|
|||||
|
2024
Q3 | $16.8M | Sell |
|
|||||
|
2024
Q2 | $7.2M | Sell |
|
|||||
|
2024
Q1 | $13.5M | Buy |
|
|||||
|
2023
Q4 | $6.74M | Sell |
|
|||||
|
2023
Q3 | $10.8M | Buy |
|
|||||
|
2023
Q2 | $22.2M | Buy |
|
|||||
|
2023
Q1 | $24M | Buy |
|
|||||
|
2022
Q4 | $39.7M | Sell |
|
|||||
|
2022
Q3 | $64.3M | Buy |
|
|||||
|
2022
Q2 | $51.3M | Buy |
|
|||||
|
2022
Q1 | $61.5M | Sell |
|
|||||
|
2021
Q4 | $82.2M | Buy |
|
|||||
|
2021
Q3 | $96M | Buy |
|
|||||
|
2021
Q2 | $123M | Sell |
|
|||||
|
2021
Q1 | $129M | Buy |
|
|||||
|
2020
Q4 | $157M | Buy |
|
|||||
|
2020
Q3 | $67.2M | Buy |
|
|||||
|
2020
Q2 | $60.5M | Buy |
|
|||||
|
2020
Q1 | $37.8M | Sell |
|
|||||
|
2019
Q4 | $62.7M | Buy |
|
|||||
|
2019
Q3 | $62.4M | Buy |
|
|||||
|
2019
Q2 | $71.1M | Buy |
|
|||||
|
2019
Q1 | $61.4M | Buy |
|
|||||
|
2018
Q4 | $58.3M | Buy |
|
|||||
|
2018
Q3 | $77M | Buy |
|
|||||
|
2018
Q2 | $57.6M | Buy |
|
|||||
|
2018
Q1 | $70.2M | Sell |
|
|||||
|
2017
Q4 | $77.1M | Sell |
|
|||||
|
2017
Q3 | $77.9M | Sell |
|
|||||
|
2017
Q2 | $61M | Sell |
|
|||||
|
2017
Q1 | $36.7M | Sell |
|
|||||
|
2016
Q4 | $22.1M | Buy |
|
|||||
|
2016
Q3 | $32.3M | Buy |
|
|||||
|
2016
Q2 | $40.3M | Buy |
|
|||||
|
2016
Q1 | $39.9M | Buy |
|
|||||
|
2015
Q4 | $61.9M | Sell |
|
|||||
|
2015
Q3 | $38.5M | Buy |
|
|||||
|
2015
Q2 | $34.3M | Buy |
|
|||||
|
2015
Q1 | $48M | Buy |
|
|||||
|
2014
Q4 | $45.2M | Buy |
|
|||||
|
2014
Q3 | $32M | Buy |
|
|||||
|
2014
Q2 | $45.2M | Sell |
|
|||||
|
2014
Q1 | $56.5M | Sell |
|
|||||
|
2013
Q4 | $44.6M | Buy |
|
|||||
|
2013
Q3 | $31.8M | Sell |
|
|||||
|
2013
Q2 | $24.3M | Buy |
|